One of the big challenges of medicine today is to deliver drugs specifically to defected cells.
Nanoparticulate drug carriers have the potential to answer to this call, as nanoparticles can …

MSNs have attracted increasing interest as drug carriers due to promising in vivo results in
small-animal disease models, especially related to cancer therapy. In most cases small …

Glucocorticoids inhibit the expression and action of most cytokines. This is part of the in vivo
feed‐back system between inflammation‐ derived cytokines and CNS‐adrenal produced …

Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple
sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 …

Mesoporous silica nanoparticles functionalized by surface hyperbranching polymerization
of poly(ethylene imine), PEI, were further modified by introducing both fluorescent and …

A series of mesoscopically ordered silicas with different pore sizes, pore connectivity, and
pore geometry have been studied as carrier matrices for controlled drug delivery systems. …

… Studies of ERPs with ADD children (Satterfield & Braley, 1977; Linden, 1991) found high …
Linden, M. (1991). Event related potentials of subgroups of attention deficit disorder children …

Since the first attempts to use standardised methods for sampling induced airways sputum,
two methods for processing the expectorate have evolved. The first involves selecting all …

… Michael Linden is affiliated with the ADD Treatment Centers, San Juan Capistrano, …
The results of the Linden et al. (1996) study reflected a significant increase on a measure of …

Spectral analysis of the electrophysiological output at a single, midline prefrontal location (the
vertex) was conducted in 482 individuals, ages 6–30 years old, to test the hypothesis that …